NeuroCRU
@NeuroCRU
Clinical Research Unit (CRU) at The Neuro - a leading centre affiliated with McGill | Unité de recherche clinique du Neuro, un centre de pointe affilié à McGill
Visit us at cru.mcgill.ca to learn more about our ongoing clinical trials. // Visitez-nous à pour obtenir plus d'information sur nos essais cliniques en cours.
Research from The Neuro's BTRC finds that neural stem cells play a role in #glioblastoma recurrence. An upcoming #clinicaltrial at Neuro CRU will study whether NOTCH receptor blockers can lead to cell maturation and slow or stop recurrence. Interview: cru.mcgill.ca/gbm-stem-cells.
📢New Platform for Advanced Clinical Therapies launches at Neuro CRU. Providing regulatory and strategic advice to preclinical researchers, designing and managing complex trials on advanced therapeutics that require specialized facilities and staff. Info: cru.mcgill.ca/pact
Exec dir Ziv Gan-Or spoke at @IRBD_StudyGroup's annual mtg. He discussed the importance of using human-derived data + models in identifying, testing new treatments for #RBD, #Parkinsons, and shared his lab’s latest findings of potential genes + biological pathways involved in RBD
🔬Plusieurs nouveaux essais cliniques visant à ralentir la progression de la #SP débuteront bientôt au NeuroCRU. 🩺Several new studies aiming to slow the progression of #MS starting soon at Neuro CRU. 📩Info: cru.mcgill.ca/ms or [email protected].
Cyrena Gerardi, gestionnaire des opérations à l'URC et Dr Simon Ducharme, chercheur principal, ont assisté au Forum Recherche clinique @Catalisquebec, réunissants des chercheurs et dirigeants de l'écosystème des sciences de la vie pour faire avancer la #rechercheclinique au #QC!
Neuro CRU is proud to take part in the largest imaging biomarker study for individuals with #FriedreichsAtaxia #FA. Results of baseline assessment of TRACK-FA were published in the Annals of Neurology. Differences with control group already apparent. bit.ly/trackfabase
NeuroCRU exec dir @ZivGanOr gave a keynote talk at @SleepEurope virtual congress discussing his lab’s work on the genetics of #RBD, allowing researchers to find #genetic targets like #GBA1 for #drugdevelopment and to identify patients who'll progress rapidly in clinical trials.
Abstract submission is open until April 10! We already have close to 50 abstracts, 10-15 of which will be selected for talks, and the rest will be presented as posters. ALL GBA1.
Hurry up and register to the GBA1 meeting in Montreal, June 5-7! And make use of the discounted hotel rooms at the conference venue! More details, including preliminary program, in the link below. Also - very generous travel awards for trainees! give.michaeljfox.org/event/gba1-mee…
CRU exec director @ZivGanOr was in Vienna for #RARE2025 to discuss his lab’s work understanding #GBA1, the genetic mutation behind a rare subtype of #Parkinsons. The CRU works to offer the most advanced investigational therapies for rare diseases, including RNA and gene therapies
En cette Journée internationale des femmes et filles de science, nous soulignons la contribution des femmes hautement qualifiées au cœur de l’Unité de recherche clinique du Neuro. Grâce à leur expertise et engagement, le Québec a fait des bonds majeurs dans la recherche. #IDWGS
Clinical trial at @TheNeuro_MNI testing #RNA therapy for #priondisease like #CJD or #GSS ranked in @NatureMedicine as one of the top trials that will shape medicine in 2025. Info: cru.mcgill.ca. #McGill
New research from @TheNeuro_MNI's Ron Postuma and @zivganor published in Jan's issue of @Brain1878 found that levels of #tau and #amyloid could help identify patient with REM Sleep Behaviour Disorder likely to develop #LewyBody Dementia. #RBD. #alzheimer bit.ly/rbddlb
A trial at The Neuro will validate whether medication for overactive bladder can help repair the neuromuscular junction in #ALS. Preclinical research by Richard Robitaille at @UMontrealwhich showed promise, improving mobility and strength in mouse models. bit.ly/3DWhJFg
🌟 L’équipe de l’Unité de recherche clinique du Neuro vous souhaite une nouvelle année remplie de santé, de bonheur et de paix! 🌟The team of the Clinical Research Unit at The Neuro wishes you a healthy, happy and peaceful new year!
Félicitations à notre collaborateur Richard Robitaille, chercheur à l'UdeM et lauréat d'un prix intl pour ses recherches sur la #SLA. Un essai clinique en cours au Neuro teste son hypothèse de l'effet de la darifénacine sur la jonction neuromusculaire. bit.ly/slarob
🧬1st patient ever for a trial on #priondisease at NeuroCRU received their 1st dose yesterday. #RNA treatment studied hopes to slow progression of rare but devastating genetic conditions like #CJD and #GSS. Interview: cru.mcgill.ca/creutzfeldt-ja…. For trials: [email protected]
De grands changements en vue pour les québécois atteints de la #dystrophiemyotonique. De nouveaux #essaiscliniques testent des traitements prometteurs ciblant le problème génétique de la #DM1. Entrevue: cru.mcgill.ca/fr/dystrophie-…. Essais: 514-398-5500; [email protected].
Rare diseases like ataxia need international collaborations to accelerate viable treatments. CRU co-director and leading #ataxia researcher Massimo Pandolfo chaired the scientific committee for #ICAR2024, which brought together 600 internationl researchers with this goal in mind.
